Literature DB >> 9623687

Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children.

Y Cai1, K Carty, R L Henry, P G Gibson.   

Abstract

We aimed to describe induced sputum cell counts in healthy nonasthmatic children, and to compare these to children with controlled and uncontrolled asthma. Following clinical assessment and spirometry, ultrasonically nebulized hypertonic saline was used to induce sputum from children with asthma (n=50) and without asthma (n=72). Sputum was dispersed and cell counts performed to yield total and differential cell counts. Specific stains were used for eosinophil and mast cell counts. All of the children with asthma were receiving inhaled and/or oral corticosteroids. Current asthma control was assessed in terms of symptoms and lung function. Children were classified as controlled on inhaled corticosteroids (no current symptoms, normal lung function n=15), current symptomatic asthma (n=16) and asthma exacerbation (n=11). It was found that eosinophils comprised a median 0.3% (interquartile range (IQR): 0, 1.05) of cells in sputum from healthy children. Sputum eosinophils (4.3% (IQR: 15, 14.1) p=0.0005) and epithelial cells (14% (IQR: 6, 19.4) p=0.0005) were significantly higher in children with asthma than in nonasthmatic children. Children whose asthma was controlled, as well as those with symptoms, had more sputum eosinophils and epithelial cells than the nonasthmatics. Mast cells were found in the sputum of only four of the 42 children with asthma. This study demonstrates that eosinophilic airway inflammation and epithelial damage can occur in children with asthma. Airway inflammation persists even in those children who are receiving inhaled corticosteroids, have normal lung function and good symptomatic control of their disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9623687     DOI: 10.1183/09031936.98.11040848

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

Review 1.  The use of sputum cell counts to evaluate asthma medications.

Authors:  K Parameswaran; F E Hargreave
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 2.  The role of inflammation in childhood asthma.

Authors:  F Chedevergne; M Le Bourgeois; J de Blic; P Scheinmann
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

Review 3.  Management of severe asthma in children.

Authors:  Andrew Bush; Sejal Saglani
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

4.  Neutrophil airway inflammation in childhood asthma.

Authors:  C M McDougall; P J Helms
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 5.  Eosinophilic bronchitis: clinical manifestations and implications for treatment.

Authors:  P G Gibson; M Fujimura; A Niimi
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

6.  Salmeterol in paediatric asthma.

Authors:  C Byrnes; S Shrewsbury; P J Barnes; A Bush
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

7.  Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity.

Authors:  N M Wilson; P Bridge; A Spanevello; M Silverman
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 8.  Changing approaches to asthma management in Australia: effects on asthma morbidity.

Authors:  E Comino; R Henry
Journal:  Drugs       Date:  2001       Impact factor: 9.546

9.  Cough frequency in children with mild asthma correlates with sputum neutrophil count.

Authors:  A M Li; T W T Tsang; D F Y Chan; H S Lam; H K So; R Y T Sung; T F Fok
Journal:  Thorax       Date:  2006-05-02       Impact factor: 9.139

10.  Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma.

Authors:  P G Gibson; J L Simpson; R Hankin; H Powell; R L Henry
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.